Trial Profile
A Phase II Study of Reduced Intensity Allogeneic Bone Marrow Transplant for the Treatment of Myelodysplastic Syndromes.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jun 2023
Price :
$35
*
At a glance
- Drugs Pentostatin (Primary) ; Ciclosporin; Methotrexate; Methoxsalen; Mycophenolate mofetil; Tacrolimus
- Indications Chronic myelomonocytic leukaemia; Graft-versus-host disease; Myelodysplastic syndromes
- Focus Therapeutic Use
- 29 Sep 2009 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
- 19 Nov 2005 New trial record.